Insulin-like growth factor 1 receptor (IGF-1R), which shares approximately 60% homology with IR, is a transmembrane tyrosine kinase activated by the binding of its ligand (IGF-1) and promotes mitogenic, metastatic, and anti-apoptotic phenotypes in breast cancer. This evidence concerns the gene IGF1 and breast cancer.